Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-54.47	8.55	18.78
Graham Fair Price	46.04	2.66	1.82
PEG	-70.15	0.09	-0.31
Price/Book	0.77	1.53	1.52
Price/Cash Flow	-70.10	19.00	63.55
Prices/Earnings	-49.61	9.69	19.23
Price/Sales	-49.96	4.53	9.05
Price/FCF	-70.10	19.00	63.55
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-9.25	0.73	0.80
Operating Margin	-11.97	0.20	0.22
ROA	100.00	< 0.005	< 0.005
ROE	0.02	0.04	100.00
ROIC	0.03	0.05	69.76
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.35	-0.17	108.87
Dividends QOQ	-0.57	0.03	-94.31
EBIT QOQ	-0.45	0.77	72.68
EPS QOQ	-0.61	1.04	68.82
FCF QOQ	2.26	2.37	4.96
Revenue QOQ	-0.50	1.01	100.84
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-554.48	-200.42	63.85
Days Sales Outstanding (DSO)	115.92	20.06	-82.69
Inventory Turnover	-0.16	-0.45	-176.66
Debt/Capitalization	0.06	0.09	43.49
Quick Ratio	1.04	4.84	366.78
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	2.74	2.83	3.26
Cash	2.84	2.81	-0.97
Capex	-0.01	-0.03	-106.53
Free Cash Flow	0.07	0.23	247.99
Revenue	0.46	0.95	107.94
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.17	6.66	468.77
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-19.17	-8.10	57.76
Naive Interpretation	Member

06 - Financial Health · Bad

Rating